Cenci MA - Search Results

1

Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia.

Lindgren HS, Rylander D, Iderberg H, Andersson M, O'Sullivan SS, Williams DR, Lees AJ, Cenci MA. Lindgren HS, et al. Among authors: cenci ma. J Parkinsons Dis. 2011;1(4):347-57. doi: 10.3233/JPD-2011-11068. J Parkinsons Dis. 2011. PMID: 23933656

2

Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment.

Cenci MA, Tranberg A, Andersson M, Hilbertson A. Cenci MA, et al. Neuroscience. 1999;94(2):515-27. doi: 10.1016/s0306-4522(99)00294-8. Neuroscience. 1999. PMID: 10579213

3

Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease.

Andersson M, Hilbertson A, Cenci MA. Andersson M, et al. Among authors: cenci ma. Neurobiol Dis. 1999 Dec;6(6):461-74. doi: 10.1006/nbdi.1999.0259. Neurobiol Dis. 1999. PMID: 10600402

4

Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.

Johansson PA, Andersson M, Andersson KE, Cenci MA. Johansson PA, et al. Among authors: cenci ma. Neurobiol Dis. 2001 Apr;8(2):220-39. doi: 10.1006/nbdi.2000.0372. Neurobiol Dis. 2001. PMID: 11300719

5

Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.

Westin JE, Andersson M, Lundblad M, Cenci MA. Westin JE, et al. Among authors: cenci ma. Eur J Neurosci. 2001 Oct;14(7):1171-6. doi: 10.1046/j.0953-816x.2001.01743.x. Eur J Neurosci. 2001. PMID: 11683909

6

cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.

Andersson M, Konradi C, Cenci MA. Andersson M, et al. Among authors: cenci ma. J Neurosci. 2001 Dec 15;21(24):9930-43. doi: 10.1523/JNEUROSCI.21-24-09930.2001. J Neurosci. 2001. PMID: 11739600 Free PMC article.

7

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA. Lundblad M, et al. Among authors: cenci ma. Eur J Neurosci. 2002 Jan;15(1):120-32. doi: 10.1046/j.0953-816x.2001.01843.x. Eur J Neurosci. 2002. PMID: 11860512

8

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.

Winkler C, Kirik D, Björklund A, Cenci MA. Winkler C, et al. Among authors: cenci ma. Neurobiol Dis. 2002 Jul;10(2):165-86. doi: 10.1006/nbdi.2002.0499. Neurobiol Dis. 2002. PMID: 12127155

9

Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Cenci MA. Cenci MA. Amino Acids. 2002;23(1-3):105-9. doi: 10.1007/s00726-001-0116-4. Amino Acids. 2002. PMID: 12373525

10

Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment.

Andersson M, Westin JE, Cenci MA. Andersson M, et al. Among authors: cenci ma. Eur J Neurosci. 2003 Feb;17(3):661-6. doi: 10.1046/j.1460-9568.2003.02469.x. Eur J Neurosci. 2003. PMID: 12581184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters